Loading decisions…
Loading decisions…
1,034 vetted Board decisions — showing the 200 most recent; use Browse by year for older decisions
The Veteran's service-connected disabilities require him to have regular aid and attendance of another person, leading to the grant of special monthly compensation based on this need.
The Board remands the claim for service connection for a pulmonary disability, claimed as sarcoidosis, to obtain additional evidence and ensure compliance with previous remand directives.
The Board has remanded the Veteran's claims for sarcoidosis of the lungs, eye disabilities, and depression with anxious features due to incomplete development and duty-to-assist errors. The issues are inextricably intertwined.
The Board dismissed the appeal as it was a proposed reduction in disability rating, not an actual final decision. The Veteran's disability rating for asthma with sarcoidosis remains at 60%.
The Veteran's claim for a higher rating for sarcoidosis prior to February 2, 2022 is being remanded due to the need for clarification on whether the prescribed Budesonide 80/Formoterol 4.5MCG (Symbicort) inhaler constitutes a low dose or high dose corticosteroid.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.